Maximal CD80-uria with minimal change

Andreas D. Kistler; Jochen Reiser

doi:10.1038/ki.2010.148

Maximal CD80-uria with minimal change

Andreas D. Kistler, Jochen Reiser

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Differentiation between minimal-change disease and focal segmental glomerulosclerosis remains challenging, particularly at early stages in children and adults. Garin et al. identify urinary CD80 excretion levels as a potential marker to differentiate the former entity from the latter. Thus, CD80 expression on podocytes, which was initially described in mouse models of foot process effacement and human lupus nephritis, is now brought toward clinical application for use as a diagnostic biomarker.

Original language	English (US)
Pages (from-to)	236-238
Number of pages	3
Journal	Kidney International
Volume	78
Issue number	3
DOIs	https://doi.org/10.1038/ki.2010.148
State	Published - Aug 2010
Externally published	Yes

ASJC Scopus subject areas

Nephrology

Access to Document

10.1038/ki.2010.148

Cite this

@article{5b92fde1feb946c29bdd8b62e8db1d50,

title = "Maximal CD80-uria with minimal change",

abstract = "Differentiation between minimal-change disease and focal segmental glomerulosclerosis remains challenging, particularly at early stages in children and adults. Garin et al. identify urinary CD80 excretion levels as a potential marker to differentiate the former entity from the latter. Thus, CD80 expression on podocytes, which was initially described in mouse models of foot process effacement and human lupus nephritis, is now brought toward clinical application for use as a diagnostic biomarker.",

author = "Kistler, {Andreas D.} and Jochen Reiser",

year = "2010",

month = aug,

doi = "10.1038/ki.2010.148",

language = "English (US)",

volume = "78",

pages = "236--238",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Maximal CD80-uria with minimal change

AU - Kistler, Andreas D.

AU - Reiser, Jochen

PY - 2010/8

Y1 - 2010/8

N2 - Differentiation between minimal-change disease and focal segmental glomerulosclerosis remains challenging, particularly at early stages in children and adults. Garin et al. identify urinary CD80 excretion levels as a potential marker to differentiate the former entity from the latter. Thus, CD80 expression on podocytes, which was initially described in mouse models of foot process effacement and human lupus nephritis, is now brought toward clinical application for use as a diagnostic biomarker.

AB - Differentiation between minimal-change disease and focal segmental glomerulosclerosis remains challenging, particularly at early stages in children and adults. Garin et al. identify urinary CD80 excretion levels as a potential marker to differentiate the former entity from the latter. Thus, CD80 expression on podocytes, which was initially described in mouse models of foot process effacement and human lupus nephritis, is now brought toward clinical application for use as a diagnostic biomarker.

UR - http://www.scopus.com/inward/record.url?scp=77954695261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954695261&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.148

DO - 10.1038/ki.2010.148

M3 - Comment/debate

C2 - 20631735

AN - SCOPUS:77954695261

SN - 0085-2538

VL - 78

SP - 236

EP - 238

JO - Kidney International

JF - Kidney International

IS - 3

ER -

Maximal CD80-uria with minimal change

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this